{"log_id": 1837425094246891808, "direction": 0, "words_result_num": 114, "words_result": [{"probability": {"variance": 0.022914, "average": 0.945853, "min": 0.369795}, "location": {"width": 306, "top": 2, "height": 37, "left": 321}, "words": "≥75×10/L的中位时间(天"}, {"probability": {"variance": 0.056447, "average": 0.78102, "min": 0.385276}, "location": {"width": 233, "top": 0, "height": 22, "left": 1264}, "words": "巴数发慢。表明"}, {"probability": {"variance": 0.008574, "average": 0.950234, "min": 0.647507}, "location": {"width": 569, "top": 6, "height": 56, "left": 916}, "words": "大剂量、长时间连续给药在促进血小板急剧生成后"}, {"probability": {"variance": 0.000296, "average": 0.992783, "min": 0.921502}, "location": {"width": 534, "top": 64, "height": 50, "left": 315}, "words": "4.糖皮质激素治疗无效的原发免疫性血小板"}, {"probability": {"variance": 0.014009, "average": 0.958723, "min": 0.426324}, "location": {"width": 584, "top": 45, "height": 56, "left": 913}, "words": "引起猴巨核系生成血小板障碍。低剂量组连续给"}, {"probability": {"variance": 0.005961, "average": 0.964871, "min": 0.723422}, "location": {"width": 312, "top": 100, "height": 43, "left": 260}, "words": "减少症(ITP)的临床研究"}, {"probability": {"variance": 0.029961, "average": 0.911206, "min": 0.355929}, "location": {"width": 577, "top": 83, "height": 54, "left": 916}, "words": "药30天对猴没有产生明显积毒性hTPO9×10"}, {"probability": {"variance": 0.003333, "average": 0.980759, "min": 0.720459}, "location": {"width": 529, "top": 139, "height": 50, "left": 317}, "words": "在多中心、随机开放、空白对照试验共纳人140"}, {"probability": {"variance": 0.006266, "average": 0.969402, "min": 0.657994}, "location": {"width": 494, "top": 121, "height": 52, "left": 913}, "words": "U/kg应视为对猕猴无明显毒副作用的剂量"}, {"probability": {"variance": 0.000264, "average": 0.990968, "min": 0.943221}, "location": {"width": 582, "top": 177, "height": 50, "left": 260}, "words": "例受试者,将糖皮质激素治疗无效的患者(血小板"}, {"probability": {"variance": 0.003012, "average": 0.973957, "min": 0.805384}, "location": {"width": 511, "top": 158, "height": 56, "left": 984}, "words": "3)致突变毒性: Thtpo对NH系小鼠骨髓"}, {"probability": {"variance": 0.00592, "average": 0.979435, "min": 0.605018}, "location": {"width": 586, "top": 214, "height": 52, "left": 258}, "words": "计数≤20×10°/L)按是否接受过脾切除进行分层"}, {"probability": {"variance": 0.007709, "average": 0.945394, "min": 0.699397}, "location": {"width": 580, "top": 196, "height": 56, "left": 911}, "words": "多染红细胞无诱发微核率升高的作用。 rhtpo3×"}, {"probability": {"variance": 0.001097, "average": 0.982519, "min": 0.868601}, "location": {"width": 569, "top": 250, "height": 52, "left": 260}, "words": "随机分组。该试验共分两个阶段:前14天为第1阶段"}, {"probability": {"variance": 0.009412, "average": 0.952673, "min": 0.564623}, "location": {"width": 365, "top": 235, "height": 39, "left": 907}, "words": "103U.1.5×103U.7.5×10U"}, {"probability": {"variance": 0.004498, "average": 0.950061, "min": 0.794306}, "location": {"width": 129, "top": 254, "height": 27, "left": 1362}, "words": "102U、1.9"}, {"probability": {"variance": 1e-06, "average": 0.996492, "min": 0.995319}, "location": {"width": 79, "top": 290, "height": 29, "left": 262}, "words": "试验"}, {"probability": {"variance": 0.024473, "average": 0.893759, "min": 0.352848}, "location": {"width": 440, "top": 290, "height": 50, "left": 404}, "words": "TPO+达那唑)rhTP1.0ug/kg"}, {"probability": {"variance": 0.000934, "average": 0.978176, "min": 0.890059}, "location": {"width": 577, "top": 271, "height": 54, "left": 913}, "words": "×102U5个剂量组均不诱发鼠伤寒沙门氏菌基因突"}, {"probability": {"variance": 0.021443, "average": 0.866598, "min": 0.634427}, "location": {"width": 152, "top": 308, "height": 31, "left": 911}, "words": "变。 hope在"}, {"probability": {"variance": 0.020828, "average": 0.930881, "min": 0.435888}, "location": {"width": 559, "top": 327, "height": 47, "left": 281}, "words": "300U/kg)皮下注射,每日次,疗程14,对照"}, {"probability": {"variance": 0.002406, "average": 0.964317, "min": 0.837578}, "location": {"width": 258, "top": 321, "height": 39, "left": 1224}, "words": "剂量下对人二倍体细胞"}, {"probability": {"variance": 0.000494, "average": 0.987515, "min": 0.932033}, "location": {"width": 577, "top": 360, "height": 52, "left": 252}, "words": "组(达那唑)在第一阶段治疗后(试验开始14天后)"}, {"probability": {"variance": 0.003777, "average": 0.975756, "min": 0.72808}, "location": {"width": 555, "top": 344, "height": 52, "left": 905}, "words": "没有致染色依畸变作用。本品在常规微核试验"}, {"probability": {"variance": 0.001997, "average": 0.980899, "min": 0.792264}, "location": {"width": 573, "top": 398, "height": 52, "left": 250}, "words": "若血小板计数仍≤20×10/L可在第二阶段加月"}, {"probability": {"variance": 0.000784, "average": 0.989354, "min": 0.877012}, "location": {"width": 461, "top": 381, "height": 47, "left": 905}, "words": "Ames试验和染色体试验的结果均为阴性"}, {"probability": {"variance": 0.002623, "average": 0.980175, "min": 0.752041}, "location": {"width": 573, "top": 434, "height": 56, "left": 252}, "words": "hTFO治疗,剂量和方法与试验组相同。结果显示"}, {"probability": {"variance": 6.1e-05, "average": 0.992124, "min": 0.976326}, "location": {"width": 150, "top": 419, "height": 39, "left": 907}, "words": "药代动力学]"}, {"probability": {"variance": 0.001985, "average": 0.983766, "min": 0.785859}, "location": {"width": 588, "top": 473, "height": 52, "left": 250}, "words": "根据第二届全国血液学学术会议制定的ITP疗效判"}, {"probability": {"variance": 0.007654, "average": 0.968135, "min": 0.618916}, "location": {"width": 515, "top": 456, "height": 56, "left": 957}, "words": "正常人单次皮下注射 Rhtpo药代动力学研究:"}, {"probability": {"variance": 0.008065, "average": 0.97001, "min": 0.569606}, "location": {"width": 584, "top": 513, "height": 50, "left": 248}, "words": "断标准中有效标准(即“显效加有数,即血小板升"}, {"probability": {"variance": 0.000946, "average": 0.983046, "min": 0.836517}, "location": {"width": 584, "top": 494, "height": 54, "left": 901}, "words": "受试者随机分为150U/Kg、300U/Kg、600U/Kg"}, {"probability": {"variance": 0.010691, "average": 0.9532, "min": 0.578006}, "location": {"width": 582, "top": 550, "height": 47, "left": 252}, "words": "至50×10°/L以上或较原水平上升30×10°/L,无或"}, {"probability": {"variance": 0.000494, "average": 0.990719, "min": 0.891972}, "location": {"width": 577, "top": 529, "height": 56, "left": 901}, "words": "三个剂量组,每组8例,共24例,结果显示在体内的"}, {"probability": {"variance": 0.001332, "average": 0.97061, "min": 0.892245}, "location": {"width": 189, "top": 586, "height": 41, "left": 248}, "words": "基本无出血症状"}, {"probability": {"variance": 2.9e-05, "average": 0.996198, "min": 0.976693}, "location": {"width": 580, "top": 567, "height": 54, "left": 899}, "words": "吸收与消除过程基本符合线性动力学特征,三个剂"}, {"probability": {"variance": 0.020841, "average": 0.92448, "min": 0.558046}, "location": {"width": 582, "top": 623, "height": 54, "left": 250}, "words": "内),试验组 RHTPO治疗达显效者(血小板计数升高"}, {"probability": {"variance": 0.013051, "average": 0.941743, "min": 0.517773}, "location": {"width": 521, "top": 603, "height": 41, "left": 699}, "words": "开始的14天量组的Tv2Ka分别为2.5±1"}, {"probability": {"variance": 0.009447, "average": 0.970631, "min": 0.48499}, "location": {"width": 582, "top": 663, "height": 50, "left": 250}, "words": "至≥100×103/L)占38.36%,明显高干对照组的"}, {"probability": {"variance": 0.01015, "average": 0.953792, "min": 0.419462}, "location": {"width": 580, "top": 644, "height": 52, "left": 899}, "words": "=2.4h,Tax分别为9.0±1.9h、10.8±2.4和11.8"}, {"probability": {"variance": 0.010528, "average": 0.958067, "min": 0.49768}, "location": {"width": 584, "top": 699, "height": 54, "left": 246}, "words": "7.94%(P=0.0002)。试验组达良效者(血小板升"}, {"probability": {"variance": 0.005277, "average": 0.962653, "min": 0.697564}, "location": {"width": 548, "top": 682, "height": 52, "left": 899}, "words": "±5.4h。 rhtpo消除比较缓慢,体内半衰期较长"}, {"probability": {"variance": 0.00613, "average": 0.971415, "min": 0.66061}, "location": {"width": 580, "top": 738, "height": 50, "left": 248}, "words": "至50×10°/L或较原水平上升30×10°/L以上)为"}, {"probability": {"variance": 0.015462, "average": 0.936683, "min": 0.519858}, "location": {"width": 561, "top": 719, "height": 54, "left": 895}, "words": "三个剂量组消除半衰期相近,分别为46.3±6.9h"}, {"probability": {"variance": 0.002373, "average": 0.982446, "min": 0.758732}, "location": {"width": 577, "top": 776, "height": 50, "left": 248}, "words": "21,92%,与对照组(28.57%)当。试验组近期有"}, {"probability": {"variance": 0.002281, "average": 0.968149, "min": 0.830074}, "location": {"width": 300, "top": 759, "height": 41, "left": 897}, "words": "40.2±9.4h.38.7±11.9h"}, {"probability": {"variance": 0.000571, "average": 0.989839, "min": 0.888968}, "location": {"width": 580, "top": 813, "height": 50, "left": 244}, "words": "效率(显效+良效达到60.27%,明显高于对照组的"}, {"probability": {"variance": 0.009006, "average": 0.968456, "min": 0.587317}, "location": {"width": 527, "top": 797, "height": 52, "left": 947}, "words": "多次皮下注射 rhtpo药代动力学研究:8名患"}, {"probability": {"variance": 0.010983, "average": 0.965845, "min": 0.575703}, "location": {"width": 231, "top": 853, "height": 35, "left": 246}, "words": "36.51%(P-0.0104"}, {"probability": {"variance": 0.012553, "average": 0.930082, "min": 0.547589}, "location": {"width": 577, "top": 832, "height": 56, "left": 890}, "words": "者分为隔日给药组(隔日皮下注射thTO1.0μg/kg,"}, {"probability": {"variance": 0.000115, "average": 0.994012, "min": 0.95568}, "location": {"width": 529, "top": 890, "height": 50, "left": 294}, "words": "其他指标显示,试验组血小板计数的最高值为"}, {"probability": {"variance": 0.000106, "average": 0.991639, "min": 0.963699}, "location": {"width": 582, "top": 870, "height": 54, "left": 890}, "words": "相当于300U/Kg,共7次)和每日给药组(每日皮"}, {"probability": {"variance": 0.010184, "average": 0.959584, "min": 0.63861}, "location": {"width": 306, "top": 928, "height": 39, "left": 248}, "words": "113.73±155.26(×10°/L"}, {"probability": {"variance": 0.001427, "average": 0.973854, "min": 0.89809}, "location": {"width": 214, "top": 938, "height": 37, "left": 603}, "words": "升高值(最高值"}, {"probability": {"variance": 0.012078, "average": 0.947179, "min": 0.511123}, "location": {"width": 577, "top": 909, "height": 52, "left": 895}, "words": "下注射rhTP01.0μg/kg,相当于300U/Kg,共14"}, {"probability": {"variance": 0.001538, "average": 0.982876, "min": 0.860235}, "location": {"width": 586, "top": 966, "height": 47, "left": 235}, "words": "基线值)为101.23+155.81(×10/L),均显著"}, {"probability": {"variance": 0.004102, "average": 0.972117, "min": 0.721968}, "location": {"width": 580, "top": 947, "height": 52, "left": 890}, "words": "天)两组,每组4例。随给药次数的增加,每个受试"}, {"probability": {"variance": 0.004619, "average": 0.969373, "min": 0.657746}, "location": {"width": 569, "top": 1001, "height": 50, "left": 235}, "words": "高于对照组的43.78±55.67(×10°/L)和33.31+"}, {"probability": {"variance": 0.000463, "average": 0.986003, "min": 0.915449}, "location": {"width": 584, "top": 982, "height": 56, "left": 884}, "words": "者的血药浓度随之升高,隔日给药组和每日给药组"}, {"probability": {"variance": 0.014288, "average": 0.950348, "min": 0.487507}, "location": {"width": 580, "top": 1039, "height": 50, "left": 237}, "words": "55.54(x10/L)(P=0,0060)。试验组 ITHTPO治"}, {"probability": {"variance": 0.004998, "average": 0.976031, "min": 0.641631}, "location": {"width": 582, "top": 1020, "height": 56, "left": 884}, "words": "的谷浓度(Cmn)分别在5次和7次给药后达到稳态"}, {"probability": {"variance": 3.2e-05, "average": 0.994993, "min": 0.97749}, "location": {"width": 584, "top": 1078, "height": 50, "left": 233}, "words": "疗14天内血小板计数值的曲线下面积中位数达到"}, {"probability": {"variance": 0.006877, "average": 0.958039, "min": 0.599906}, "location": {"width": 575, "top": 1059, "height": 52, "left": 884}, "words": "水平,稳态Cma分别为1637±969pg/ml和290"}, {"probability": {"variance": 0.003603, "average": 0.969811, "min": 0.718706}, "location": {"width": 519, "top": 1114, "height": 50, "left": 235}, "words": "92.50,明显高于对照组的229.25(P=0.000"}, {"probability": {"variance": 0.011452, "average": 0.943975, "min": 0.573404}, "location": {"width": 580, "top": 1097, "height": 54, "left": 884}, "words": "士1736pg/ml。两组的峰浓度(Cmx)的变化趋"}, {"probability": {"variance": 0.001222, "average": 0.985367, "min": 0.836336}, "location": {"width": 586, "top": 1153, "height": 50, "left": 229}, "words": "试验组25%患者达到有效的时间为7天,对照组为10"}, {"probability": {"variance": 0.013354, "average": 0.949876, "min": 0.567349}, "location": {"width": 577, "top": 1135, "height": 54, "left": 880}, "words": "势与谷浓度相似,稳态峰Cmzx分别为2135±"}, {"probability": {"variance": 0, "average": 0.999586, "min": 0.999586}, "location": {"width": 31, "top": 1191, "height": 31, "left": 231}, "words": "天"}, {"probability": {"variance": 0.020583, "average": 0.938458, "min": 0.450698}, "location": {"width": 571, "top": 1174, "height": 52, "left": 895}, "words": "095pg/ml和4193±3436pg/ml。每个受试者第1"}, {"probability": {"variance": 0.009933, "average": 0.969302, "min": 0.525614}, "location": {"width": 527, "top": 1231, "height": 47, "left": 285}, "words": "亚组分析显示,未接受牌切除受试者(FAS集"}, {"probability": {"variance": 0.016268, "average": 0.955828, "min": 0.365552}, "location": {"width": 586, "top": 1210, "height": 54, "left": 876}, "words": "次给药后的AUC以及Tak和2等药代动力学参数"}, {"probability": {"variance": 0.004533, "average": 0.977181, "min": 0.686141}, "location": {"width": 573, "top": 1266, "height": 50, "left": 227}, "words": "64:55)试验组有效率为57.81%,对照组为32.37%"}, {"probability": {"variance": 0.001086, "average": 0.989726, "min": 0.840188}, "location": {"width": 580, "top": 1247, "height": 54, "left": 880}, "words": "与末次给药后相比无明显差异,即无时间依赖性的"}, {"probability": {"variance": 0.000978, "average": 0.982157, "min": 0.868168}, "location": {"width": 586, "top": 1304, "height": 50, "left": 225}, "words": "两组间差异显著。接受脾切除受试者(FAS集8:9)"}, {"probability": {"variance": 0.000282, "average": 0.988455, "min": 0.93708}, "location": {"width": 584, "top": 1285, "height": 54, "left": 876}, "words": "药代动力学变化。多次皮下注射hTPO,血药浓度"}, {"probability": {"variance": 0.008047, "average": 0.967589, "min": 0.548698}, "location": {"width": 584, "top": 1341, "height": 52, "left": 223}, "words": "因例数较少无法评价。对于基线小于10×10°/L的"}, {"probability": {"variance": 0.001399, "average": 0.984788, "min": 0.829869}, "location": {"width": 577, "top": 1322, "height": 54, "left": 876}, "words": "升高的水平与给药的累积剂量正相关,在给药14次"}, {"probability": {"variance": 0.000111, "average": 0.989736, "min": 0.9519}, "location": {"width": 571, "top": 1379, "height": 50, "left": 225}, "words": "受试者,试验组有效率FAS)为54.05%(20/37)"}, {"probability": {"variance": 1.3e-05, "average": 0.996634, "min": 0.990509}, "location": {"width": 319, "top": 1362, "height": 43, "left": 874}, "words": "内,药物在体内无积倾向"}, {"probability": {"variance": 0.002671, "average": 0.960232, "min": 0.88715}, "location": {"width": 75, "top": 1402, "height": 29, "left": 872}, "words": "[贮藏"}, {"probability": {"variance": 0.014214, "average": 0.945668, "min": 0.528401}, "location": {"width": 580, "top": 1416, "height": 50, "left": 223}, "words": "对照组为34.48(10/29):对于基线小于5×10°/L"}, {"probability": {"variance": 0.01363, "average": 0.950265, "min": 0.455623}, "location": {"width": 580, "top": 1452, "height": 54, "left": 219}, "words": "的受试者,试验组有效率(EAS)为45.45%(5/11)"}, {"probability": {"variance": 0.001074, "average": 0.978136, "min": 0.899478}, "location": {"width": 242, "top": 1439, "height": 41, "left": 966}, "words": "8℃避光保存和运输"}, {"probability": {"variance": 9.1e-05, "average": 0.993133, "min": 0.979665}, "location": {"width": 66, "top": 1475, "height": 31, "left": 868}, "words": "[包装"}, {"probability": {"variance": 0.003042, "average": 0.973063, "min": 0.777402}, "location": {"width": 559, "top": 1491, "height": 52, "left": 221}, "words": "对照组为41.67%(5/12)。差异均无统计学意义"}, {"probability": {"variance": 0.003065, "average": 0.975299, "min": 0.772927}, "location": {"width": 527, "top": 1531, "height": 50, "left": 273}, "words": "临床试验中 rhtpo相关不良反应请参见不良反"}, {"probability": {"variance": 0.000639, "average": 0.980993, "min": 0.937869}, "location": {"width": 175, "top": 1512, "height": 43, "left": 924}, "words": "西林瓶装,1瓶"}, {"probability": {"variance": 0, "average": 0.999468, "min": 0.99902}, "location": {"width": 87, "top": 1569, "height": 31, "left": 217}, "words": "应部分"}, {"probability": {"variance": 0.000741, "average": 0.973632, "min": 0.935574}, "location": {"width": 95, "top": 1552, "height": 31, "left": 865}, "words": "有效期"}, {"probability": {"variance": 1e-06, "average": 0.999064, "min": 0.998269}, "location": {"width": 118, "top": 1608, "height": 31, "left": 225}, "words": "药理毒理]"}, {"probability": {"variance": 3e-06, "average": 0.998833, "min": 0.995654}, "location": {"width": 83, "top": 1592, "height": 31, "left": 922}, "words": "36个月"}, {"probability": {"variance": 8.5e-05, "average": 0.98737, "min": 0.972508}, "location": {"width": 125, "top": 1627, "height": 31, "left": 868}, "words": "[执行标准]"}, {"probability": {"variance": 0, "average": 0.999555, "min": 0.999115}, "location": {"width": 54, "top": 1648, "height": 29, "left": 310}, "words": "药理"}, {"probability": {"variance": 0.001563, "average": 0.975416, "min": 0.864084}, "location": {"width": 532, "top": 1681, "height": 54, "left": 267}, "words": "血小板生成素( (thrombopoietin,TFO)是刺"}, {"probability": {"variance": 0.001278, "average": 0.969432, "min": 0.854386}, "location": {"width": 250, "top": 1667, "height": 37, "left": 920}, "words": "WS4-(S-024)-2010Z"}, {"probability": {"variance": 0.004903, "average": 0.979207, "min": 0.667557}, "location": {"width": 586, "top": 1717, "height": 54, "left": 210}, "words": "激巨核细胞长及分化的内源性细胞因子,对巨核"}, {"probability": {"variance": 4.5e-05, "average": 0.993439, "min": 0.980315}, "location": {"width": 125, "top": 1702, "height": 33, "left": 868}, "words": "批准文号]"}, {"probability": {"variance": 0.00461, "average": 0.975309, "min": 0.726982}, "location": {"width": 582, "top": 1756, "height": 50, "left": 212}, "words": "细胞生成的各阶段均有刺激作用,包括前体细胞的"}, {"probability": {"variance": 0.013976, "average": 0.950592, "min": 0.424932}, "location": {"width": 381, "top": 1740, "height": 45, "left": 934}, "words": "700U/lml,国药准字20050049"}, {"probability": {"variance": 0.000526, "average": 0.976381, "min": 0.93682}, "location": {"width": 87, "top": 1781, "height": 25, "left": 920}, "words": "15000U"}, {"probability": {"variance": 0.000155, "average": 0.992057, "min": 0.953412}, "location": {"width": 586, "top": 1792, "height": 54, "left": 210}, "words": "增殖和多倍体巨核细胞的发育及成熟,从而升高血"}, {"probability": {"variance": 0.004843, "average": 0.956152, "min": 0.76613}, "location": {"width": 231, "top": 1786, "height": 33, "left": 1089}, "words": "国药字S20150048"}, {"probability": {"variance": 0.009447, "average": 0.948348, "min": 0.6152}, "location": {"width": 584, "top": 1829, "height": 54, "left": 208}, "words": "小板数目。重组人血小板生成素( (RHTPO)是利用"}, {"probability": {"variance": 2e-06, "average": 0.998167, "min": 0.996468}, "location": {"width": 118, "top": 1815, "height": 33, "left": 870}, "words": "生产企业]"}, {"probability": {"variance": 0.001123, "average": 0.982085, "min": 0.876096}, "location": {"width": 588, "top": 1869, "height": 52, "left": 206}, "words": "基因重组技术由中国仓鼠卵巢细胞表达,经提纯制"}, {"probability": {"variance": 0.000974, "average": 0.987018, "min": 0.864423}, "location": {"width": 456, "top": 1852, "height": 50, "left": 911}, "words": "企业名称:沈阳三生制药有限责仟公司"}, {"probability": {"variance": 0.008277, "average": 0.976034, "min": 0.559629}, "location": {"width": 582, "top": 1907, "height": 50, "left": 208}, "words": "成的全长糖基化血小板生成素,与内源性血小板生"}, {"probability": {"variance": 0.027323, "average": 0.908615, "min": 0.465843}, "location": {"width": 573, "top": 1890, "height": 52, "left": 911}, "words": "生产地址:沈阳经济技术开发国十号路1甲3号8"}, {"probability": {"variance": 1.1e-05, "average": 0.996392, "min": 0.989037}, "location": {"width": 452, "top": 1944, "height": 47, "left": 204}, "words": "成素具有相似的升高血小板的药理作用"}, {"probability": {"variance": 0.000449, "average": 0.989245, "min": 0.923079}, "location": {"width": 219, "top": 1930, "height": 37, "left": 909}, "words": "邮政编码:110027"}, {"probability": {"variance": 0.00506, "average": 0.968064, "min": 0.689019}, "location": {"width": 507, "top": 1986, "height": 47, "left": 283}, "words": "次大剂量Coy射线全身照射猕猴造成骨髓"}, {"probability": {"variance": 0.036256, "average": 0.813706, "min": 0.373222}, "location": {"width": 563, "top": 1963, "height": 60, "left": 911}, "words": "电话和传真号码:024-251802425121传真8"}, {"probability": {"variance": 0.008644, "average": 0.956493, "min": 0.614862}, "location": {"width": 279, "top": 2005, "height": 43, "left": 909}, "words": "网址:http://www.3s"}, {"probability": {"variance": 0, "average": 0.821954, "min": 0.821954}, "location": {"width": 18, "top": 2026, "height": 18, "left": 1266}, "words": "n"}], "language": -1}